The famous San Francisco Victorian from ‘Full House’ is on the market for $6.5 million, and it’s gorgeous inside
This TV-famous abode memorably featured on the ABC sitcom has been fully renovated by the show’s creator
Carrefour shares skid on report of possible fine
Shares of French supermarket giant Carrefour slumped on Tuesday after a report the French government wanted to levy a 200 million euro fine.
Treasury yields steady ahead of retail sales data
Bond yields were little changed early Tuesday as traders awaited the U.S. retail sales report for May.
Troubled EV maker Fisker files for bankruptcy protection
The electric vehicle maker Fisker on Tuesday said it filed for bankruptcy protection, a step that came as little surprise after recently defaulting on a bond payment and halting manufacturing.
Yogis who stole millions from ailing Malibu doctor expose the perils caregivers can pose to the vulnerable
Anthony David Flores was sentenced to nearly 16 years in prison.
La-Z-Boy is opening new stores, despite expectations for ‘volatile’ furniture demand
Shares of La-Z-Boy Inc. rallied after hours on Monday after the maker of recliners and other furniture reported fourth-quarter results that topped expectations.
Adobe sued by U.S. regulators for making it too difficult to cancel subscriptions
U.S. regulators on Monday sued on Adobe Inc., accusing the software company and two executives of “deceiving consumers” by hiding the termination fee for a popular subscription plan and making it too difficult for customers to cancel subscriptions.
Chegg says it’s doubling down on students while cutting nearly a quarter of its staff
The digital-education platform Chegg Inc. on Monday said it would slash nearly a quarter of its staff, a move it said would free up space for longer-term investments as it tries to offer more than just academic guidance to students and use more artificial intelligence.
Why Palantir’s ‘highly volatile’ stock is worth a buy, according to a new bull
Palantir is ‘giving the market what it wants in terms of margin expansion and profitability,’ says an Argus analyst.
Merck’s vaccine approval poses threat to one of Pfizer’s top-selling products
Merck has gained U.S. regulatory approval for a vaccine that could become a tough competitor to one of Pfizer Inc.’s top-selling products.
